0.4 ML adalimumab-aaty 100 MG/ML Prefilled Syringe
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
0.4 ML adalimumab-aaty 100 MG/ML Prefilled Syringe
100 MG/ML · Prefilled Syringe · injection
A form of adalimumab-aaty →
0.4 ML adalimumab-aaty 100 MG/ML Prefilled Syringe — Tumor necrosis factor alpha (TNF-alpha) inhibitors. Strength, form, class, interactions & more.
Active ingredient
Classification
Tumor necrosis factor alpha (TNF-alpha) inhibitorsTumor Necrosis Factor Blocker
Drug interactions
Adalimumab-aaty has several drug interactions that may increase the risk of serious infections or require monitoring of concomitant medications.
- majorabatacept — Increased risk of serious infection
- majoranakinra — Increased risk of serious infection
- majorlive vaccines — Avoid use
- moderateCYP450 substrates with a narrow therapeutic index (e.g., warfarin, cyclosporine, theophylline) — Monitoring of the effect or drug concentration is recommended
Real-world adverse events (FAERS)
Drug Ineffective10,241Off Label Use7,989Rheumatoid Arthritis5,564Fatigue5,324Pain5,322Arthralgia5,079Rash4,516Condition Aggravated4,353
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication